Figure 1A illustrates the observed downregulation of plasma SLC26A4-AS1 in patients with rectal cancer compared to healthy controls. SLC26A4-AS1 expression was decreased in the included rectal cancer cells compared with normal cells FHC and aberrantly decreased in SW1463 and SNU-283 cells (Figure 1B). Here, SLC26A4 is linked to rectal cancer.